NCT06638216Completed
Prospective Evaluation of Frailty in Patients With Head and Neck Tumors Before Curative Intended Therapy
Source: ClinicalTrials.gov · Last updated 28 Aug 2025
Brief summary (registry, in English)
In a prospective study the fragility of patients with head and neck tumors before the start of curative therapy will be assessed. Primary objective: Fragility is assessed using the G8 questionnaire. Secondary objectives include the assessment of quality of life and financial burden (EORTC-QLQ C30+ H\&N43), swallowing function, cardiopulmonary resilience (6-minute walk test) and the patient's wishes regarding a prehabilitation program. Epidemiological and disease-related data is also collected.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 99 (actual)
- First submitted
- 6 Oct 2024
- Start date
- 7 Oct 2024
- Primary completion date
- 12 Jun 2025
- Lead sponsor
- Charite University, Berlin, Germany
- Diseases
- Head and neck cancer
- NCT number
- NCT06638216
What you commit to
- Study type: Interventional
- Participants enrolled: 99
- From 7 Oct 2024 to the primary completion date, 12 Jun 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Severe impairment of walking ability that makes it impossible to perform the 6MWT safely
- Contraindications for performing a 6MWT:
- Absolute contraindications\* for the procedure are
- unstable angina pectoris
- myocardial infarction in the past month.
- Relative contraindications are
- a resting heart rate \> 120/min
Age
- Age \<18 years
Other
- \- Lack of capacity to consent
- systolic blood pressure \> 180 mmHg
- a diastolic blood pressure \> 100 mmHg.
Who the study is looking for
- Indication for curative therapy in the case of an initial diagnosis of head and neck tumor disease
- Capacity to consent
- At least 18 years of age
- Sufficient knowledge of the German language
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Charité - University Medicine Berlin Coordinator of this site? Confirm its status | Berlin | Germany | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.